Popular Content
Advertisement
Featured Articles





View Full Article

Intra-abdominal Infections in Adults 4/14/2016

These conditions constitute the second leading cause of infection-related mortality in the ICU.


View Full Article

Legionnaires’ Disease and Pontiac Fever 4/14/2016

Infected individuals usually require hospitalization and may be treated with a number of antibiotics.


View Full Article

Lyme Disease: The Pharmacist’s Role in Treatment and Prevention 4/14/2016

Pharmacists can assist in early identification, antimicrobial selection and dosing, and monitoring of response.


View Full Article

Management of Invasive Aspergillosis 4/14/2016

Aspergillosis, which is most commonly observed in immunocompromised persons, is a significant cause of morbidity and mortality in this population, with mortality rates as high as 90%.
View Full Article

Prevention and Management of Genital Herpes 4/14/2016

Genital herpes is a major public-health concern because of its recurrent nature, its ability to be transmitted asymptomatically, and its potential for complications.
View Full Article

Urinary Tract Infections: Causes and Treatment Update 4/14/2016

Two new IV antibiotics that act against multidrug-resistant bacteria are welcome additions to pharmacologic therapy.


Chronic Post-ICU Pain and Post–Intensive Care Syndrome 3/17/2016

Many patients continue to experience significant discomfort for months or years after ICU discharge.


Clinical Management of Neuropathic Low Back and Neck Pain 3/17/2016

A multidisciplinary approach is necessary to assist patients in achieving a reduction in pain.


Mucositis in Cancer Patients: A Review 3/17/2016

Mucositis—the breakdown of epithelial cells in the gastrointestinal tract—is a common and painful side effect of treatment for many cancer patients.

National Pain Strategy: Implications for Pharmacy Practice 3/17/2016

The National Pain Strategy is a comprehensive population health-level plan that addresses the issue of inadequate pain management in the United States, as well as the national opioid-abuse epidemic.

New Pharmacotherapy Options for Hyperphosphatemia 3/17/2016

Oral phosphate binders are widely used in clinical practice for patients with end-stage renal disease.


NSAIDs: Balancing the Risks and Benefits 3/17/2016

The FDA has strengthened the warnings regarding cardiovascular risk with NSAID use.


Pharmacist Involvement in Hospice and Palliative Care 3/17/2016

The number of patients in need of hospice and palliative care continues to grow, as do the general population’s knowledge and awareness of the diagnosed conditions that render patients eligible for hospice care services.

Treatment of Fibromyalgia Pain 3/17/2016

Fibromyalgia syndrome, which was first described more than 100 years ago, is defined as chronic, widespread musculoskeletal pain characterized by both somatic and psychological symptoms.

Breaking Down Glioma: A Pharmacist’s Overview 2/17/2016

Gliomas are central nervous system tumors that arise from glial cells in the brain or spine.

Cardiovascular Complications of Ketoacidosis 2/17/2016

Electrolyte disturbances and catecholamine release can result in acute cardiovascular changes.


Dual Antiplatelet Therapy Duration in Patients With Drug-Eluting Stents 2/17/2016

Complications seen with percutaneous coronary intervention led to the development of bare metal stents and, later, drug-eluting stents.

Medications Associated With Implantable Cardiac Devices 2/17/2016

Pharmacists must know how drugs affect the efficacy and safety of these devices.


Monoclonal Antibodies for the Treatment of Hypercholesterolemia 2/17/2016

Cholesterol concentrations in many patients with familial hypercholesterolemia are poorly controlled despite dietary changes and maximum pharmacologic therapy.

Recommending Aspirin for Primary Prevention of Cardiovascular Disease 2/17/2016

Aspirin has long been used for its anti-inflammatory and analgesic properties, and more recently it has been used for its antithrombotic effect in reducing cardiovascular disease risk.
For more articles, please check our archives.
Advertisement